Cryo-Save logo CryoSave

Investor
Relations

CryoSave, the leading international stem cell storage brand and the largest family stem cell bank in Europe, is an established healthcare services group which focuses on the collection, processing and storage of human adult stem cells. CryoSave has already stored more than 300,000 samples from umbilical cord blood and umbilical cord tissue.

CryoSave is listed on NYSE Euronext Amsterdam (ticker: CRYO) and is a profitable, cash generative business, which pays a dividend. CryoSave has a highly scalable business model with significant operational gearing.

In being the leading international family stem cell bank, CryoSave recognises its responsibility to proactively contribute to building knowledge and expertise in adult stem cell applications and research. CryoSave’s educational program aims to increase global awareness of stem cell therapy and the potential of regenerative medicine amongst healthcare professionals and local communities. This education provides the fundamentals for CryoSave’s sustainable growth; increasing both market size and market share in existing markets.